The burden of varicella from a parent's perspective and its societal impact in The Netherlands: an Internet survey

BMC Infectious Diseases

Volumn 11, Issue , 2011, Pages

  Wolleswinkel van den Bosch, Judith H ^a   Speets, Anouk M ^a   Rümke, Hans C ^b   Gumbs, Pearl D ^c   Fortanier, Sander C ^c  

^a Health Research and Consultancy BV   (Netherlands)

^b p/a Erasmus Medisch Centrum   (Netherlands)

^c GLAXOSMITHKLINE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; BALANCE DISORDER; CHICKENPOX; CHILD; CLINICAL FEATURE; COLD; CONTROLLED STUDY; CONVULSION; COUGHING; DIARRHEA; EATING DISORDER; FEMALE; FEVER; HEALTH CARE PLANNING; HEALTH CARE SYSTEM; HEALTH CARE UTILIZATION; HEALTH SURVEY; HUMAN; INTERNET PROTOCOL; LISTLESSNESS; MAJOR CLINICAL STUDY; MALE; MARKETING; MEDICAL HISTORY; MOTOR DYSFUNCTION; NETHERLANDS; PARENT; PATHOGEN LOAD; PRESCHOOL CHILD; PRODUCTIVITY; PRURITUS; QUESTIONNAIRE; RETROSPECTIVE STUDY; SKIN BLEEDING; SKIN INFECTION; SKIN INFLAMMATION; SLEEP DISORDER; SOCIAL ASPECT; UNCONSCIOUSNESS; VOMITING; CROSS-SECTIONAL STUDY; HEALTH SERVICE; INFANT; INTERNET; PATHOLOGY; UTILIZATION REVIEW;

ADULT; CHICKENPOX; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; EFFICIENCY; FEMALE; HEALTH SERVICES; HUMANS; INFANT; INTERNET; MALE; NETHERLANDS; PARENTS; QUESTIONNAIRES;

EID: 81155124465     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-11-320     Document Type: Article

References (35)

1. de Melker H, Berbers G, Hahné S, Rümke H, van den Hof S, de Wit A, Boot H. The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination. Vaccine 2006, 24:3946-3952. 10.1016/j.vaccine.2006.02.017, 16564115.
2. Boot HJ, de Melker HE, Stolk EA, de Wit GA, Kimman TG. Assessing the introduction of universal varicella vaccination in the Netherlands. Vaccine 2006, 24:6288-6299. 10.1016/j.vaccine.2006.05.071, 16790302.
3. Heiniger U, Seward JF. Varicella. Lancet 2006, 368:1365-76. 10.1016/S0140-6736(06)69561-5, 17046469.
4. Marin M, Meissner HC, Seward JF. Varicella prevention in the United States: a review of successes and challenges. Pediatrics 2008, 122:e744-e751. 10.1542/peds.2008-0567, 18762511.
5. de Wit GA, Verweij A, van Baal PHM, Vijgen SMC, van den Berg M, Busch MCM, Barnhoorn MJM, Schuit AJ. Economic evaluation of prevention: further evidence. Bilthoven 2007,
6. Harbers MM, van der Wilk EA, Kramers PGN, Kuunders MMAP, Verschuuren M, Eliyahu H, Achterberg PW. Dare to compare! Benchmarking Dutch health with the European Community Health Indicators (ECHI). RIVM report number 270051011 2008, Houten: Bohn Stafleu Van Loghum.
7. Oostenbrink J, Koopmanschap MA, Rutten FFH. Handleiding voor kostenonderzoek - Methoden en standaard kostprijzen voor economische evaluaties in de gezondheidszorg (Guide to cost research - Methods and standard costs prices for economic evaluations in healthcare). Amstelveen 2004,
8. Brouwer WB, Koopmanschap MA, Rutten FF. Productivity losses without absence: measurement validation and empirical evidence. Health Policy 1999, 48:13-27. 10.1016/S0168-8510(99)00028-7, 10539583.
9. Koopmanschap MA. PRODISQ: a modular questionnaire on productivity and disease for economic evaluation studies. Expert Rev Pharmacoecon Outcomes Res 2005, 5:23-28. 10.1586/14737167.5.1.23, 19807557.
10. van Roijen L, Essink-Bot ML, Koopmanschap MA, Bonsel G, Rutten FF. Labor and health status in economic evaluation of health care. The Health and Labor Questionnaire. Int J Technol Assess Health Care 1996, 12:405-415. 10.1017/S0266462300009764, 8840661.
11. Banz K, Wagenpfeil S, Neiss A, Hammerschmidt T, Wutzler P. The burden of varicella in Germany. Potential risks and economic impact. Eur J Health Econ 2004, 5:46-53. 10.1007/s10198-003-0200-7, 15452764.
12. Eurostat Internet usage in the EU25. Eurostat News Release 2006, 146. Eurostat.
13. Halldórsson M, Kunst AE, Köhler L, Mackenbach JP. Socioeconomic differences in children's use of physician services in the Nordic countries. J Epidemiol Community Health 2002, 56:200-204. 10.1136/jech.56.3.200, 1732105, 11854341.
14. Schonlau M, Zapert K, Simon LP, Sanstad KH, Marcus SM, Adams J, Spranca M, Kan H, Turner R, Berry SH. A Comparison Between Responses From a Propensity-Weighted Web Survey and an Identical RDD Survey. Social Science Computer Review 2004, 22:128-138.
15. Díez-Domingo J, Gil A, San-Martín M, González A, Esteban J, Baldó JM, Planelles MV, Ubeda MI, Graullera M, Peris A, et al. Seroprevalence of varicella among children and adolescents in Valencia, Spain. Reliability of the parent's reported history and the medical file for identification of potential candidates for vaccination. Hum Vaccin 2005, 1:204-206. 10.4161/hv.1.5.2216, 17012857.
16. Heininger U, Baer G, Bonhoeffer J, Schaad UB. Reliability of varicella history in children and adolescents. Swiss Med Wkly 2005, 135:252-255.
17. Bonanni P, Breuer J, Gershon A, Gershon M, Hryniewicz W, Papaevangelou V, Rentier B, Rümke H, Sadzot-Delvaux C, Senterre J, et al. Varicella vaccination in Europe - taking the practical approach. BMC Med 2009, 7:26. 10.1186/1741-7015-7-26, 2697173, 19476611.
18. Deguen S, Chau NP, Flahault A. Epidemiology of chickenpox in France (1991-1995). J Epidemiol Community Health 1998, 52(Suppl 1):46S-49S.
19. Díez-Domingo J, Aristegui J, Calbo F, Gonzalez-Hachero J, Moraga F, Peña GJ, Ruiz CJ, Torrellas A. Epidemiology and economic impact of varicella in immunocompetent children in Spain. A nation-wide study. Vaccine 2003, 21:3236-3239. 10.1016/S0264-410X(03)00264-0, 12804853.
20. Emery C, Lancon F, Fagnani F, Pechevis M, Durand I, Floret D. ENVOL study on the medical management of varicella and its complications in French ambulatory care [French]. Med Mal Infect 2006, 36:92-98. 10.1016/j.medmal.2005.12.001, 16460897.
21. Fornaro P, Gandini F, Marin M, Pedrazzi C, Piccoli P, Tognetti D, Assael BM, Lucioni C, Mazzi S. Epidemiology and cost analysis of varicella in Italy: results of a sentinel study in the pediatric practice. Italian Sentinel Group on Pediatric Infectious Diseases. Pediatr Infect Dis J 1999, 18:414-419. 10.1097/00006454-199905000-00004, 10353513.
22. Rentier B, Gershon AA, . European Working Group on Varicella Consensus: varicella vaccination of healthy children--a challenge for Europe. Pediatr Infect Dis J 2004, 23:379-389. 10.1097/01.inf.0000122606.88429.8f, 15131459, European Working Group on Varicella.
23. Wagenpfeil S, Neiss A, Banz K, Wutzler P. Empirical data on the varicella situation in Germany for vaccination decisions. Clin Microbiol Infect 2004, 10:425-430. 10.1111/j.1469-0691.2004.00853.x, 15113320.
24. Wolleswinkel-van den Bosch JH, Stolk EA, Francois M, Gasparini R, Brosa M. The health care burden and societal impact of acute otitis media in seven European countries: results of an Internet survey. Vaccine 2010, 28(Suppl 6):G39-G52.
25. Rack AL, Grote V, Streng A, Belohradsky BH, Heinen F, von KR, Liese JG. Neurologic varicella complications before routine immunization in Germany. Pediatr Neurol 2010, 42:40-48. 10.1016/j.pediatrneurol.2009.07.012, 20004861.
26. Liese JG, Grote V, Rosenfeld E, Fischer R, Belohradsky BH, Kries R, . ESPED Varicella Study Group The burden of varicella complications before the introduction of routine varicella vaccination in Germany. Pediatr Infect Dis J 2008, 27:119-124. 10.1097/INF.0b013e3181586665, 18227713, ESPED Varicella Study Group.
27. Grimprel E, Levy C, de La RF, Cohen R, Soubeyrand B, Caulin E, Derrough T, Lecuyer A, d'Athis P, Gaudelus J. Paediatric varicella hospitalisations in France: a nationwide survey. Clin Microbiol Infect 2007, 13:546-549. 10.1111/j.1469-0691.2007.01706.x, 17378927.
28. Dubos F, Grandbastien B, Hue V, Martinot A. Epidemiology of hospital admissions for paediatric varicella infections: a one-year prospective survey in the pre-vaccine era. Epidemiol Infect 2007, 135:131-138. 10.1017/S0950268806006467, 2870539, 16740185.
29. van Enk JG. Determinants of use of health care services in childhood. PhD Thesis 2002, Rijksuniversiteit Groningen.
30. Mangen MJJ, Havelaar AH, Bernsen RAJAM, van Koningsveld R, de Wit GA. The costs of human Campylobacter infections and sequelae in the Netherlands: A DALY and cost-of-illness approach. Acta Agricuilturae Scandinavica Section C Food Economics 2005, 2:35-51.
31. van den Brandhof WE, de Wit GA, de Wit MA, van Duynhoven YT. Costs of gastroenteritis in The Netherlands. Epidemiol Infect 2004, 132:211-221. 10.1017/S0950268803001559, 2870096, 15061495.
32. Thiry N, Beutels P, van Damme P, van Doorslaer E. Economic evaluations of varicella vaccination programmes: a review of the literature. Pharmacoeconomics 2003, 21:13-38.
33. Bonanni P, Boccalini S, Bechini A, Banz K. Economic evaluation of varicella vaccination in Italian children and adolescents according to different intervention strategies: the burden of uncomplicated hospitalised cases. Vaccine 2008, 26:5619-5626. 10.1016/j.vaccine.2008.07.096, 18723062.
34. Rozenbaum MH, van Hoek AJ, Vegter S, Postma MJ. Cost-effectiveness of varicella vaccination programs: an update of the literature. Expert Rev Vaccines 2008, 7:753-782. 10.1586/14760584.7.6.753, 18665775.
35. European Foundation for the Improvement of Living and Working Conditions (Eurofound) Working conditions in the European Union: The gender perspective. Luxembourg 2007, European Foundation for the Improvement of Living and Working Conditions (Eurofound).